Wealth Enhancement Advisory Services
CRMD icon

Wealth Enhancement Advisory Services’s CorMedix CRMD Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$242K Sell
33,011
-3,458
-9% -$27.7K ﹤0.01% 3570
2026
Q2 		$306K Buy
36,469
+12,164
+50% +$96.1K ﹤0.01% 3184
2026
Q1 		$171K Sell
24,305
-3,235
-12% -$23.9K ﹤0.01% 3190
2025
Q4 		$310K Buy
27,540
+1,707
+7% +$18.9K ﹤0.01% 2895
2025
Q3 		$286K Sell
25,833
-3,281
-11% -$39.7K ﹤0.01% 2840
2025
Q2 		$338K Buy
29,114
+1,478
+5% +$16.3K ﹤0.01% 2550
2025
Q1 		$170K Sell
27,636
-3,409
-11% -$35.3K ﹤0.01% 2663
2024
Q4 		$251K Sell
31,045
-21,139
-41% -$211K ﹤0.01% 2517
2024
Q3 		$422K Buy
52,184
+4,935
+10% +$26.7K ﹤0.01% 1939
2024
Q2 		$205K Buy
47,249
+3,064
+7% +$15.6K ﹤0.01% 2283
2024
Q1 		$187K Buy
44,185
+1,157
+3% +$4.01K ﹤0.01% 2215
2023
Q4 		$162K Buy
43,028
+1,955
+5% +$6.73K ﹤0.01% 2120
2023
Q3 		$152K Buy
+41,073
New +$163K ﹤0.01% 2045

Other funds holding CRMD

HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Wealth Enhancement Advisory Services's CRMD Position: Q3 2026 in Review

Wealth Enhancement Advisory Services reduced its CorMedix (CRMD) stake by 9.5% in Q3 2026, selling an estimated $27.7K and leaving 33,011 shares worth $242K. The position accounts for ﹤0.01% of the portfolio, ranked #3570.

Wealth Enhancement Advisory Services first reported a position in CRMD in Q3 2023 and has held it in 13 quarters since. The position peaked at $422K in Q3 2024. 5 funds tracked by Wall St. Rank hold CRMD as of Q3 2026.

  • Wealth Enhancement Advisory Services held 33,011 shares of CorMedix worth $242K as of Q3 2026.
  • Wealth Enhancement Advisory Services sold 3,458 CorMedix shares in Q3 2026, an estimated $27.7K.
  • CorMedix made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q3 2026, its #3570 holding.
  • Wealth Enhancement Advisory Services first reported a position in CorMedix in Q3 2023 and has held it in 13 quarters since.
  • Wealth Enhancement Advisory Services's CorMedix position peaked at $422K in Q3 2024.
  • 5 funds tracked by Wall St. Rank held CorMedix as of Q3 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q3 2026, filed 13 Oct 2026.